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1. Introduction 
Autism is a developmental lifelong condition of the human brain, and a behavioral 
characterization as a spectrum (autism spectrum disorder: ASD) is the best way to illustrate 
this complex trait (Frith, 2001; Rapin, 1997; Wing, 1997). The predominant presence of 
autistic cases without comorbidity (idiopathic or primary ASD) (Freitag, 2007) clearly means 
that the biological effects associated with the known concomitant medical conditions 
(cytogenic abnormalities, fragile X syndrome, tuberous sclerosis, congenital infections, 
maternal thalidomide use, epilepsy, etc.) cannot be the common prerequisite for ASD at 
least in the majority of the cases. The presence of a strong genetic contribution is evident 
from the results of twin studies, which demonstrated that 70-90% of monozygotic twins are 
concordant for ASD, and the concordance in dizygotic twins and the recurrence rate in the 
proband’s siblings are both less than 10% (Rapin & Katzman, 1998). A broadening of the 
criteria of diagnosis leads the monozygotic concordance ratio to more than 90%, but 100% 
concordance is never obtained (Rapin & Katzman, 1998). Therefore, it is claimed that genetic 
factors contribute about 90% to ASD with environmental factors contributing no more than 
10% (Garber, 2007). Although a flood of genetic information in the field of ASD is 
continuously growing, even the newest genome-wide molecular studies cannot detect the 
universal genetic prerequisite for idiopathic cases with ASD, compelling some researchers to 
speculate that ASD has a huge inter-case heterogeneity of the related gene variants.  
Many gene variants, which seem to affect brain development and synaptic functions, have 
been reported in association with the autistic development (Betancur, 2011; Garber, 2007; 
Persico & Bourgeron, 2006; Pinto et al., 2010). In families with the candidates for autism gene 
variants, however, the strict co-segregation, in which the gene variant is found only in 
individuals with ASD among family members including parents, is still exceptional (Table 
1). To explain this fact, the broader distribution of the more primary phenotype or pre-
behavioral phenotype (endophenotype) beyond the categorical border is introduced as the 
speculative solution through this research maze (Viding & Blakemore, 2007). It may be quite 
difficult to detect and evaluate such endophenotypes because of the configurational or 
hierarchical structures of human cognitions and behaviors. Even if such speculations were 
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all true, it is too early to conclude that “a single gene variant causes a small percentage of 
cases with this complex trait” (Garber, 2007; Beaudet, 2007). As clearly demonstrated in the 
case of human disease-associated mutations found as wild-type alleles in normal chimpanzee 
(L. Azevedo et al., 2006), a deleted or mutated allele does not necessarily contribute to the 
disease development. Because evidence consistent with a theory is not proof of that theory 
(Cannell, 2010), until one could delineate the molecular or biological trajectory underlying 
autistic development which is quantitatively different from the parents, there is still a huge 
black box between the de novo variant allele and complex human behaviors in the sporadic 
cases with idiopathic ASD. The reported gene variants are, at present, nothing but one of the 
concomitants in a small percentage of cases (5-7%, in Table 1). The possibility that the 
variantsare mere relative risk factors remains to be elucidated (Jones & Szatmari, 2002). As a 
general rule, a genetic link does not necessarily imply neurological damage (Simpson, 
  
Variants 
 
Prevalence References 
SHANK3 variants In ASD families 15 / 227 (6.6%)a (Durand et al., 2007) 
 Co-segregated cases 3 / 227 (1.3%)b 
 In controls 5 / 270 (1.9%)a 
SHANK3 variants In ASD families 3 / 400 (0.8%)c (Moessner et al., 2007) 
SHANK3 variants In ASD individuals 34 / 427 (8.0%) (Gauthier et al., 2009) 
 In controls 16 / 190 (8.4%) 
SHANK3 deletion In ASD individuals 1 / 427 (0.2%)c (Gauthier et al., 2009) 
 In controls 0 / 190 
SHANK3 deletion In ASD individuals 2 / 2,195 (0.1%) (Glessner et al., 2009) 
 In controls 2 / 2,519 (0.1%) 
SHANK2 de novo deletion In ASD individuals 2 / 996 (0.2%) (Pinto et al., 2010) 
 In controls 0 / 1,287, 0 / 3,677
NLGN3 variants In ASD individuals 0 / 96 (Yan et al., 2005) 
NLGN3 duplication In ASD individuals 1 / 2,195 (0.05%) (Glessner et al., 2009) 
 In controls 0 / 2,519 
NLGN4 variants In ASD individuals 4 / 148 (2.7%)d (Yan et al., 2005) 
 In controls 0 / 336 
NRXN1 deletion In ASD families 1 / 1,181 (0.1%) (AGPC, 2007) 
NRXN1┙ variants In ASD individuals 5 / 116 (4.3%) (Yan et al., 2008) 
 In controls 1 / 192 (0.5%)
NRXN1 deletion In ASD individuals 10 / 2,195 (0.5%) (Glessner et al., 2009) 
 In controls 0 / 2,519
NRXN1 de novo variants In ASD families 4 / 996 (0.4%) (Pinto et al., 2010) 
 In controls 5 / 1,287 (0.4%)
NRXN1┚ variants In ASD individuals 4 / 203 (2.0%)d,e (Feng et al., 2006) 
 In controls 0 / 535
NRXN2┚ variants In ASD individuals 0 / 72 (Feng et al., 2006) 
NRXN3┚ variants In ASD individuals 0 / 72 (Feng et al., 2006) 
CNTN4 deletion In ASD individuals 10 / 2,195 (0.5%) (Glessner et al., 2009) 
 In controls 0 / 2,519
CNTN4 duplication In ASD individuals 9 / 2,195 (0.4%)c (Glessner et al., 2009) 
 In controls 1 / 2,519 (0.04%) 
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Variants 
 
Prevalence References 
AUTS2 In ASD individuals 1 / 2,195 (0.05%) (Glessner et al., 2009) 
 In controls 0 / 2,519 
DDX53/PTCHD1 deletion In ASD cases 7 / 996 (0.7%) (Pinto et al., 2010) 
(maternally inherited) In controls 0 / 1,287, 0 / 3,677
CNVs at 15q11-13 In ASD individuals 15 / 2,195 (0.7%)f (Glessner et al., 2009) 
(UBE3A) In controls 0 / 2,519 
CNVs at 15q11-13 In ASD individuals 4 / 522 (0.8%)g (Depienne et al., 2009) 
CNVs at 16p11.2 In ASD families 12 / 751 (1.6%) (Weiss et al., 2008) 
 In controls 5 / 4,234 (0.1%) 
 In ASD individuals 3 / 299 (1.0%) 
 In controls 7 / 18,834 (0.04%) 
16p11.2 duplication In ASD individuals 9 / 2,195 (0.4%)c (Glessner et al., 2009) 
 In controls 4 / 2,519 (0.2%) 
16p11.2 deletion In ASD individuals 8 / 2,195 (0.4%)h (Glessner et al., 2009) 
 In controls 4 / 2,519 (0.2%) 
CNV gain at 1q21 In ASD families 3 / 1,181 (0.3%)d (AGPC, 2007) 
CNV at 17p12 In ASD families 3 / 1,181 (0.3%)i (AGPC, 2007) 
CNV gain at 22q11.2 In ASD families 2 / 1,181 (0.2%)d (AGPC, 2007) 
22q11.2 duplication In ASD individuals 9 / 2,195 (0.4%) (Glessner et al., 2009) 
 In controls 0 / 2,519 
De novo CNVs In ASD families 10 / 1,181 (0.8%) (AGPC, 2007) 
 Co-segregated cases 3 / 1,181 (0.3%)j 
De novo CNVs In ASD individuals 14 / 195 (7.2%)k (Sebat et al., 2007) 
 In sporadic cases 12 / 118 (10.2%) 
 In multiplex families 2 / 77 (2.6%) k 
 In controls 2 / 196 (1.0%) 
De novo CNVs In ASD families 27 / 427 (6.3%) (Marchall et al., 2008) 
 In sporadic cases 4 / 56 (7.1%) 
 In multiplex families 1 / 49 (2.0%) 
De novo CNVs In ASD families 50 / 876 (5.7%)l (Pinto et al., 2010) 
 In simplex families 22 / 393 (5.6%) 
 In multiplex families 19 / 348 (5.5%) 
ASDs: autism spectrum disorders; NLGN: neuroligin gene; NRXN: neurexin gene; CNTN: contactin 
gene; AUTS: autism susceptibility candidate gene; CNV: copy number variation; AGPC: the Autism 
Genome Project Consortium. aTwo nonsynonymous SHANK3 mutations were revealed in 4 ASD 
families and 2 control individuals. bIn the SHANK3 study, de novo truncating mutations in two families 
and a chromosomal rearrangement in one family were demonstrated as the strict co-segregated cases 
whose gene variants were found only in individuals with ASD among family members including 
parents. cOne de novo case is included. dStrict co-segregation was not shown. eTwo cases with mild facial 
dysmorphism are included. fTwo de novo cases are included. gThree de novo cases are included. hFive de 
novo cases are included. iOne case is included as a co-segregated family. jIn ASD families with two or 
more affected individuals (multiplex families), three de novo CNVs were found in both ASD sibs. kTwo 
multiplex families whose variant-phenotype co-segregation is not mentioned are included. l>0.6% cases 
are carrying two or more de novo events. 
Table 1. The prevalence of variants in gene regions recently implicated in idiopathic ASD 
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2003), and high heritability does not vindicate the condition as a diagnostic category (Keller 
& Miller, 2006). There is as yet no qualitative biological marker including microscopic 
lesions that can reliably help to categorize a genetically homogeneous autism subtype 
(Amaral et al., 2008; Moldin et al., 2006; Santangelo & Tsatsanis, 2005; Schmitz & Rezaie, 
2008). In this article, the significance of gene variants which have currently been detected in 
autistic individuals is carefully reconsidered and the outstanding questions are addressed 
from multidisciplinary points of view. Such an attempt may highlight the importance of the 
notion that the evolutionally survived trait is the phenotypic diversity itself, in which ASD 
is included as an extreme tail. In addition, important concepts and mechanisms for the 
genetic basis of phenotypic diversity are also reviewed. 
2. Facts and questions 
Although some authorities appreciated the smooth behavioral continuum between 
individuals with ASD and the non-autistic majority (Frith, 2001; Happé, 1999; Rapin, 1997; 
Wing, 1997), idiopathic ASD has sometimes been misinterpreted as a qualitative disorder 
which can be clearly distinguished from normal development. The boundary between 
individuals with low-functioning ASD and a communicative subtype (Asperger syndrome) 
has also been misrepresented as to be qualitatively distinct (Simpson, 2003). Even the 
differentiation between Asperger syndrome and high-functioning ASD could be made with 
authority (Kamp-Becker et al., 2010). These biased constructions may be attributable to 
referral bias in general practice or increased probability of clinical ascertainment in 
individuals with low achievement (Skuse, 2007). Although ASD can still be documented as a 
categorical entity in clinically ascertained samples (Frazier et al., 2010), the fact that the 
autistic phenotype extends beyond its formal diagnostic boundaries has underscored the 
significance of quantitative evaluations (Lamb et al., 2000; Maestrini et al., 2000), and many 
population studies revealed that ASD including high-functioning subtypes are best 
characterized as an extreme of some bell-shaped behavioral dimensions that distribute 
quantitatively (Constantino & Todd, 2000; Constantino & Todd, 2003; Happé et al., 2006; 
Hoekstra et al., 2007; Posserud et al., 2006; Ronald et al., 2005; Ronald et al., 2006a, 2006b; 
Skuse et al., 2005). The description ‘qualitative’ in the autism criteria in the Diagnostic and 
Statistical Manual of Mental Disorders (DSM) is removed and Asperger’s disorder 
(Asperger syndrome) is subsumed into ASD in the draft of DSM-5 (http://www.dsm5.org 
/Pages/Default.aspx). The three quantitative domains including sociability, 
communication, and rigid/repetitive behavior correlate modestly to each other in the 
population (Dworzynski et al., 2007; Ronald et al., 2005, 2006a, 2006b), and the coincidence 
of these phenotypic extremes is also observed in hyperactive individuals with attention-
deficit/hyperactivity disorder (AD/HD) (Hattori et al., 2006; Ijichi & Ijichi, 2007; Reiersen et 
al., 2007; Ronald et al., 2008). The diagnosis of autism is highly affected by the circumstantial 
consequence of social adaptability and autistic recognition and behavior sometimes does not 
become fully manifest until social demands exceed the individual’s limited capacities (the 
draft of DSM-5). The clinical picture can change with increasing age and in different 
circumstances (Wing, 1997), and the behavioral plasticity or clinical improvement is evident 
in supportive circumstances by structured behavioral interventions, mentoring, and/or 
social involvement with appropriate accommodation (Garcia-Villamisar & Hughes, 2007; 
Ijichi & Ijichi, 2007; McGovern & Sigman, 2005; Tonge et al., 1994). 
The most unique and potentially meaningful property of autistic cognition is savant skill. 
The estimated prevalence of the cognitive superiority in ASD varies from 10% to surprising 
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numbers (Dawson et al., 2007; Happé, 1999; Rapin & Katzman, 1998). The supposed 
common ‘high intelligence’ in autistic individuals with low IQ may involve high processing 
speed, prodigious memory capacities, and heightened primary sensory processing 
(Boddaert et al., 2005; McCleery et al., 2007; Scheuffgen et al., 2000). These cognitive 
superiorities are believed to have the same origin as the social difficulties in ASD (Brosius & 
Kreitman), and the term, ‘autistic savant skills’, is used to describe one of the core cognitive 
features of ASD (Badcock & Crespi, 2006; Scheuffgen et al., 2000). As a unifying explanation 
which covers the manifold autistic characteristics, excessive neuronal processing (a hyper-
functionality model) is also implicated as opposed to usual hypo-functionality explanations 
(Markram et al., 2007). 
The ratio of sibling recurrence risk to population prevalence is approximately 50 with an 
overwhelming predominance of sporadic cases, suggesting the multifactorial nature of ASD 
(AGPC, 2007). The high monozygotic concordance rate in twins and the modest recurrence 
risk in dizygotic twins and among siblings may also suggest that the genetic architecture for 
ASD has the same complexity as those for human physical appearances including facial 
characteristics and brain gray matter volume (Ijichi & Ijichi, 2004). In traditional views, the 
modest correlation between autistic behavioral domains in population studies implies that 
there is no single (genetic or endophenotypical) cause for the three autistic extreme 
characteristics and a mere coincidence of the phenotypic extremes might be the true nature 
of autistic social difficulties (Happé et al., 2006). Although positive assortative mating might 
cause phenotypic anticipation and a negative assortative mating between the couple might 
gather the non-overlapping genetic components in a baby (Ijichi et al., 2008), there is no 
evidence for such assortative mating (Hoekstra et al., 2007). 
As exemplified in Table 1, there is, so far, no universal genetic marker which is co-
segregated with ASD in the affected families. In contrast to the early prediction (30-40%) 
(Beaudet, 2007), no more than 5-7% of ASD cases may be traceable to single or multiple 
genetic concomitant(s) (Table 1). Although many whole-genome scans for autism 
susceptibility loci have identified a lot of linkage peaks, the reproduction of the results is 
exceptional and association studies have failed to identify the gene variants (Sykes & Lamb, 
2007). The regions of structural variants including copy number variations (CNVs) seldom 
conform to the linkage peaks (Sebat, 2007). The lack of an unambiguous pathophysiological 
marker is also one of the important characteristics of idiopathic autism (Amaral et al., 2008; 
Moldin et al., 2006; Santangelo & Tsatsanis, 2005; Schmitz & Rezaie, 2008). The only 
anatomical candidate which can be consistently co-segregated with ASD including masked 
autistic savants may be a quantitative increase in the number of processing units of cortex 
(minicolumns) (Casanova, et al., 2002, 2007). The increase in the number of minicolumns is 
thought to be associated with mammalian brain evolution, and the finding can explain other 
apparent tendencies revealed in some autistic individuals, including increases in the volume 
of brain structures and the prevalence of epilepsy (Casanova et al., 2006). Recent 
preliminary findings suggest that the tendency of brain overgrowth originates prenatally 
(Hobbs et al., 2007; Leonard et al., 2008). Furthermore, there is no biological deficit including 
chemical and molecular findings which is universal in individuals with ASD or can reliably 
help to identify putative subgroups that are genetically homogeneous (Lauritsen & Ewald, 
2001). Over-expression of neuron-associated genes is still one of the candidates for 
molecular markers (Lepagnol-Bestel et al., 2008; Maussion et al., 2008; Rinaldi et al., 2007). 
The scientific puzzle, which is metaphorically described as “myopic investigators are still 
patting the elephant” (Rapin, 1999) remains to be solved (Baron, 2008). Why is the male to 
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female ratio biased (3-4 to 1)? Why cannot the behavioral uniformity with strong genetic 
contribution be interpreted by common gene variant alleles? Why is the disparity between 
monozygotic and dizygotic concordances so large? Why do the autistic behavioral domains 
correlate modestly? Although these questions may provide very important clues and are 
encouraging researchers to speculate on reasons, the jigsaw is still incomplete. Missing 
puzzle pieces include the solution of the evolutionary mystery of autism prevalence. Human 
conditions can be selected and survive when it is somehow associated with increased 
reproductive success (Nesse & Williams, 1994). However, in spite of the hypo-reproductive 
tendency of behaviors in extreme cases with ASD (Lord et al., 2000), the estimated high 
prevalence has never declined (Baird et al., 2006; CDC, 2009; Fombonne, 2009). 
3. Genetic and environmental explanations 
It is recently recognized that ASD has the highest prevalence (more than 0.5%) in childhood 
neurodevelopmental conditions (CDC, 2009; Fombonne, 2009). In traditional frameworks, in 
which researchers are searching the human genome for the condition-specific genetic variants, 
three genetic models should be considered as the genetic mechanism for such a common 
phenotypic condition (Gibson, 2009). The quite low effect size of each ASD-related variant is 
suggested to be the cause of difficulty in replication of the positive findings in the common 
disease-common variant (CD-CV) model (Anney, 2010). Although a rare alleles of major effect 
(RAME) model is one of the core principles for recent genome-wide association studies in ASD 
(Gibson, 2009), the replication may also be complicated by chance findings, as well as 
differences in ascertainment, because of the modest relative risk of the rare alleles (Anney, 
2010). The third model, the infinitesimal model, can make an excuse for the situation of genetic 
studies, because it is very hard to identify rare variants of small effect by genetic means 
(Manolio et al., 2009). It is, anyhow, clear that it’s time to reconsider and question simple 
intuitive models that link a human complex condition to mutation (Gibson, 2009). 
3.1 Genetic factors 
The non-universality of the candidate gene variants which have previously been implicated 
in ASD may be consistent with the speculation that heterogeneous sets of gene variants can 
contribute to ASD (Betancur, 2011; Beaudet, 2007; Garber, 2007). Furthermore, in order to 
explain the modest correlations between the three autistic behavioral domains, the presence 
of domain-specific heterogeneous sets of gene variants are also suggested (Happé et al., 
2006). However, even novel genetic means including whole genome screening using 
microarray-based hybridization cannot fully confirm these speculations (Table 1). The 
frequent absence of diagnostic history of ASD in the parents of an idiopathic ASD proband 
may suggest that the supposed variants should be carried by a non-ASD parent (incomplete 
penetrance) or the proband should have de novo mutations (Beaudet, 2007; Constantino & 
Todd, 2005; Zhao et al., 2007) (Table 2). However again, such genetic transmission is still one 
of the hypotheses and the concomitant de novo variants can be detected only in a minor part 
of the cases (Table 1). The number of candidate gene regions is still increasing without a 
convincing and comprehensive demonstration of the link between such variants and autistic 
developmental trajectory (Glessner et al., 2009). 
The genetic contribution to a quantitative trait may be attributable to the cumulative effect 
of a set of quantitative trait loci (QTLs) (Plomin et al., 1994, 2009; Plomin & Kosslyn, 2001). 
Each QTL is neither necessary nor sufficient for the overall phenotypic outcomes, the effect 
size of each QTL may fluctuate according to other genetic backgrounds (epistasis, non-
www.intechopen.com
The Genetic Basis of Phenotypic Diversity: 
Autism as an ExtremeTail of a Complex Dimensional Trait 
 
89 
additive gene-gene interactions) and the environment (gene-environment interactions), and a 
QTL may affect more than one phenotypic trait (pleiotropy). The concept of epistasis had 
initially been introduced for ASD as an alternative explanation of the incomplete penetrance or 
as a risk factor model (Bradford et al., 2001; Folstein & Rosen-Sheidley, 2001; Jones & Szatmari, 
2002). Because natural chromosomal and segmental shuffling during normal meiosis is a 
strong random modifier of epstatic effects among QTLs in a sib-pair and dizygotic twins, the 
big disparity between monozygotic and dizygotic concordances in autism may be explained 
by the presence of epistatic QTLs. Pleiotropy can account for the presence of autistic savants. 
The modest correlation among autistic behavioral domains can also illustrated by 
unsynchronized epistatic pleiotropy (Ijichi et al., 2008). To explain the sporadic manner of the 
prevalence and the survival of hypo-reproductive autistic extremes, the implication of 
epistasis-associated intergenerational oscillation of phenotypic outcomes was introduced 
(Ijichi et al., 2008). Some candidates for autism QTLs have been reported (Ashley-Koch et al., 
2006; Coutinho et al., 2007; Jiang et al., 2004; Weiss et al., 2007), linkage analysis with 
quantitative measures of some autistic characteristics revealed QTL signals (Alarcón et al., 
2002, 2005; Chen et al., 2006; Duvall et al., 2007), and a quantitative covariance analysis can 
confirm the high genetic correlation between ‘social motivation’ and ‘range of 
interest/flexibility’ (Sung et al., 2005). Although the supposed contribution of QTLs ought to 
be traced in family studies or genome scans according to a traditional logic, “the causal gene 
variant can be cosegregated with the phenotypic variant”, the delay and difficulty in detecting 
the causal variant alleles at QTLs is strangely common to all idiopathic quantitative traits 
including autism, physical and physiological characteristics, and personalities (de Geus et al., 
2001; Fullerton, 2006; Palmert & Hirschhorn, 2003; Willis-Owen & Flint, 2006). 
 
Facts and questions Explanations 
Penetrance De novo QTLs Environment 
The quantitative feature (○) － ○ (○) 
Partial behavioral plasticity － － － ○ 
The presence of autistic savants － － (○) － 
Strong genetic contribution ○ ○ ○ － 
Usually sporadic without family history (○) ○ (○) ○ 
Domain-specific genetic factors － － (○) － 
Lack of the common genetic marker ○ ○ ○ － 
Lack of the common pathological lesion － － － － 
Lack of the common chemical marker － － － － 
Lack of the common molecular marker － － － － 
Why is the male to female ratio biased? (○) (○) (○) (○) 
Why is it so difficult to detect autism 
genes? 
－ － － － 
Why do hypo-reproductive extremes 
survive? 
－ ○ － (○) 
Penetrance: Poor penetrance of heterogeneous gene variants; De novo: De novo involvement of 
heterogeneous gene variants; QTLs: Quantitative trait loci; Environment: Environmental contribution; ○: 
explainable; (○): unexplainable by itself but explainable with some further speculation; －: hard to explain 
Table 2. Genetic and environmental explanations for the facts and outstanding questions in 
idiopathic autism researches 
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3.2 Epigenetic factors and ASD 
Phenotypic outcomes with robustness or plasticity cannot be exclusively determined by the 
DNA sequence itself which looks like the core genetic factor of the phenotype (Goldberg et 
al., 2007). Epigenetics is the study of changes in gene expression that occur without a change 
in DNA sequence and the epigenotype is meiotically and mitotically transmissible (Morris, 
2005; van Vliet et al., 2007). Although the significance of the contribution made by epigenetic 
factors to human complex traits remains unclear, it is speculated that epigenetic factors can 
influence gene-environment interactions and the liability/outcomes of the traits (van Vliet et 
al., 2007). Epigenetic changes in gene expression are achieved through RNA-associated 
silencing, DNA methylation, and histone modifications (Morris, 2005), and cis-acting 
expansion of the epigenetic influences on the flanking genes is referred to as genomic 
imprinting which results in parent of origin-specific gene expression (Pauler et al., 2007). 
The epigenetic factors and genomic imprinting may be implicated in syndromic autistic 
individuals with some single gene/chromosomal disorders including Rett syndrome, fragile 
X syndrome, Prader-Willi syndrome, and Angelman syndrome, and a variety of factors 
associated with epigenetic modifications have been considered as candidates for autism 
genes (Badcock & Crespi, 2006; Jiang et al., 2004; Persico & Bourgeron, 2006; Schanen, 2006; 
Skuse, 2000; van Vliet et al., 2007). These factors, however, cannot be the common 
prerequisite for idiopathic ASD at least in the majority of the cases (Jiang et al., 2004; Persico 
& Bourgeron, 2006), and the power of epigenetic factors are recognized as an accidental cue 
to shift the quantitative distribution of the autistic traits in a threshold model (Skuse, 2000). 
If the epigenetic factors act only in gene-environment interactions in idiopathic cases, the 
epigenetic contribution should be modest in the overall underpinnings. Given an unforeseen 
transmissible powerful architecture connecting genotype and phenotype for phenotypic 
diversity independent of genetic diversity, the epigenetic mechanism should be referred to 
as merely one of the molecular-level environments derived from gene networks. 
3.3 Environmental factors 
Environmental factors contribute no more than 10% to ASD (Garber, 2007). However, the 
environmental factors including rubella, thalidomide, and valproic acid embryopathies may 
still be important as additive triggers of the clinical manifestation (Jones & Szatmari, 2002; 
Persico & Bourgeron, 2006). Environmental contributions including behavioral experiences 
are originally misunderstood to explain the patterns of familial recurrence risks observed in 
autism studies (Jorde et al., 1991). Because the genetic components affecting autistic traits 
seem to be the same across the sexes (Constantino & Todd; Hoekstra et al., 2007), it can be 
speculated that the lower prevalence of autistic traits in girls is the result of increased 
sensitivity to early environmental influences that operate to promote social competency 
(Constantino & Todd, 2003). The minimal contribution of shared environmental influences 
(Ronald et al., 2006a) may be associated with the autistic behavioral manifestations 
including resistance to change or insistence on sameness. 
Combinations of the traditional theories (poor penetrance, de novo mutations, and QTLs and 
the environmental contribution) may answer not a few of the outstanding questions in 
idiopathic autism research (Table 2). However, in spite of the presence of a big genetic 
contribution to the autistic development, the question, “Why is it difficult to detect autism 
gene variants?”, still remains to be resolved. In addition, the significance of both de novo 
mutations and the environmental modification is just a speculation in a part of the ASD 
cases. 
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4. Evolutionary explanations 
Does idiopathic ASD really represent many distinct conditions with numerous etiologies 
(Geschwind, 2007)? Is it really time to give up on a single explanation for autism (Baron, 
2008; Happé et al., 2006)? A variety of qualitative concomitants, including gene variants and 
environmental factors, have already been demonstrated in part of autistic cases as 
exemplified above. However, it may be still too early to reach the conclusion even in such 
frameworks, because no single qualitative process associated with the concomitants can 
indicate the molecular or chemical differences between the autistic developmental extremes 
and the non-autistic majority. In order to understand human complex traits, genetic, 
molecular, and biochemical explanations should be combined with evolutionary 
explanations (Nesse & Williams, 1994). In autistic individuals, ASD per se does not shorten 
the span of life (Gillberg et al., 2010). Although high or preserved androgenic competence is 
suspected in ASD (Tordjman et al., 1997), the extreme cases almost never marry (Lord et al., 
2000). The hypo-fertility results from reduced opportunity or behavioral ability in the 
mating arena. Therefore, we must probe into who is enjoying the reproductive benefits of 
the genetic architecture for ASD in the evolutionary framework (Table 3). 
 
Who gets the reproductive 
benefits? 
Hypotheses or mechanisms References 
None (an inevitable 
outcome) 
Mutation-selection balance theory (Keller & Miller, 2006) 
Unaffected carriers of genetic 
factors 
Hyper-systemizing theory 
(extreme male brain theory) 
Extreme imprinted brain theory 
(Baron-Cohen, 2002) 
 
(Badcock & Crespi, 2006) 
All of the non-autistic 
majority 
Population benefit theory 
Monomorphic loci theory 
(Fitzgerald, 2002) 
(Ijichi et al., 2011) 
Table 3. Evolutionary explanations for the survival of autistic extremeness 
4.1 Mutation-selection balance theory 
In the mutation-selection balance theory, individuals with a high load of mutations are 
postulated to be at higher chance of passing risk on to their offspring, and it is not necessary 
that there are individuals with the reproductive benefits (Keller & Miller, 2006). 
Importantly, according to the proposed model, everyone alive has minor brain deviations 
that cause them to be a little bit abnormal in behavioral and cognitive dimensions (Keller & 
Miller, 2006). The non-autistic majority in the population is regarded as the genetic carrier-
state for ASD and the mutation load and the risk of having autistic offspring may vary 
quantitatively. In the mutation-selection balance theory, balancing selection for genetic 
diversity is recognized to be unsuitable to explain persistent heritability in human 
conditions (Keller & Miller, 2006; Zhang & Hill, 2005). One of the grounds of this exclusion 
of balancing selection is the absence of an ongoing homeostatic mechanism that counteracts 
the homogenizing effect of genetic drift and stabilizing selection, and the reproductive 
benefits of the genetic burden for autism are not addressed (Keller & Miller, 2006). The 
mutation-selection perspective can be an evolutionary interpretation of a cumulative effect 
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of de novo mutations and is at least consistent with the quantitative distribution of autistic 
domains. 
4.2 Extreme male brain theory 
The second is a group of theories in which only a part of the population is regarded as the 
genetic carrier-state for ASD. The prevalence or maintenance of positive assortative mating 
between the non-autistic carriers is critical to accumulate genetic factors in these theories, 
and the remaining non-autistic majority does not have the genetic components for ASD. In 
the hyper-systemizing theory, the unaffected carriers of the genetic factors are high 
systemizers and ASD is the result of both parents being the high systemizers (Baron-Cohen, 
2002, 2004, 2006). Systemizing is the drive to understand and predict the next step of 
inanimate events and acts contrary to empathizing. In males, the systemizing mechanism is 
set at a slightly higher level than non-autistic males (Baron-Cohen, 2004). This extreme male 
brain theory of autism had originally been proposed by Asperger in 1944. Individuals 
including both parents of individuals with autism, who are placed in the adjacent part to the 
autistic extremeness, systemize at a higher level than average (above average systemizers) 
and account for approximately a half of the vast majority. Over successive generations, the 
above average systemizers carry the genetic components for ASD and might enjoy the 
reproductive benefits. As one of the genetic bases of the hyper-systemizing theory, the 
extreme imprinted brain theory had been proposed (Badcock & Crespi, 2006). 
4.3 Population benefit theory and individual benefit theory 
In the third framework, it is suggested that the evolutionarilly selected and conserved 
phenotype is not the hypo-reproductive extremeness but the whole quantitative distribution 
itself. A group selection theory has been introduced to bring sense into the link between 
autism and exceptional creativity (Fitzgerald, 2003). In this population benefit theory, the 
creativity, which can be concomitant with autism, benefits all members of the human 
community and the community can survive. On the other hand, the third framework can 
also include individual benefit concepts (the monomorphic loci theory) (Ijichi et al., 2011). In 
the individual benefit concepts, everybody has both the genetic architecture for ASD and the 
possibility to enjoy the reproductive benefits of autism genes. Each phenotypic outcome, 
however, varies individually mainly according to the differences in genetic background 
noise and environmental factors, whose functions are not necessarily related to ASD 
phenotypes directly. In the process of reaching the monomorphic loci theory, the epistasis-
mediated intergenerational oscillation of phenotypic outcomes has been advanced in a QTL 
model (Ijichi et al., 2008). The monomorphic loci theory does not dismiss the comprehensive 
view of the known genetic contributions, including major gene effects and additive genetic 
networks (Ijichi et al., 2011). The postulated involvement of monomorphic loci can be valid 
as merely one of the genetic constituents in complex (additive and/or non-additive) 
interactions with polymorphic loci.  
4.4 The monomorphic loci theory and gene networks 
Because both positive and negative epistasis may be byproducts of evolution (L. Azevedo et 
al., 2006; R.B.R. Azevedo et al., 2006; Harrison et al., 2007), the invisibility of the contribution 
of monomorphic epistatic loci from the traditional genetic view is an attractive candidate for 
the explanation of the black box between polymorphic genotype and phenotypic diversity 
(Ijichi et al., 2011). Complex phenotypes have hierarchical structures, including RNA 
www.intechopen.com
The Genetic Basis of Phenotypic Diversity: 
Autism as an ExtremeTail of a Complex Dimensional Trait 
 
93 
(transcript traits), protein, metabolite, and functional levels. It has been suggested that less 
heritability of metabolite traits than transcript traits is associated with the difference in the 
quantity of biological noise between the genetic determinants and the trait (Rowe et al., 
2008). The more steps that are involved between genotype and the trait level, the more 
biological noise may reside in the process. Such biological noise originates from inter-locus 
interactions and gene-environment interactions, and the inter-locus interactions may have 
an important role in the biological noise. Additive and/or non-additive inter-locus 
interactions with other loci are available in a variety of processes including cis-, trans-, and 
inter-cellular interactions (Figure 1). The presence of gene-environment-gene circuits may 
make it difficult to distinguish inter-locus interactions from gene-environment interactions 
in the biological noise (Ijichi et al., 2011). In these interactions, an intergenerational change in 
the number or property of factors (environment and/or other related loci) in the regulatory 
circuit may easily individualize the balance of each hierarchical trajectory (coding RNA, 
non-coding RNA, translation, autocrine, paracrine, and endocrine levels) and individually 
determine the developmental outcomes. The net non-additive effects of the biological noise 
are metaphorically interpreted as hub-and-spoke structures of regulatory networks among 
polymorphic loci (Benfey & Mitchell-Olds, 2008). 
 
 
Fig. 1. Cellular and molecular interactions of biological noise in regulatory networks around a 
gene locus (A). Additive and/or non-additive phenomena can be involved in each interaction 
(Ijichi et al., 2011). In this explanation, an arrow represents the net contribution between loci 
and the gene-environment relationship. The locus A can interact with other loci in association 
with coding RNA and/or non-coding RNA level in cis-acting manner (ձ, ղ) and trans-acting 
manner (ճ, մ). The cis-acting interactions are involved in genetic imprinting. After 
translation, interactions can be mediated through autocrine, paracrine, and endocrine 
mechanisms (յ, ն). Gene-environment interactions can modify penetrance of the outcomes 
affected by the locus A. The network constituents can change the sensitivity to environmental 
influences (շ), that can provide gene-environment-gene circuits. In the monomorphic loci 
theory, the gene A can be monomorphic and the link between monomorphic A and the A-
associated polymorphic noise is usually invisible in the context of traditional genetics. 
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5. Quantitative domains and genetic factors 
The distributional shift of a bell-shaped curve and the change in the curve shape illustrates 
the mean value change and the variance alteration of the quantitative dimension, 
respectively (Gibson, 2009). These changes can affect the proportion of individuals with 
autism to those without as determined by a liability threshold. The biased male to female 
ratio (3-4 to 1) in ASD is plausibly interpreted as a distributional shift of the quantitative 
bell-shaped curve as a gender gap. In the hyper-systemizing theory, the male systemizing 
mechanism is set at a slightly higher level than in females (Baron-Cohen, 2004). In an 
imprinted-X liability threshold model, actions of some X-linked genes, which are expressed 
only from paternal X-chromosome, are suggested to be associated with the male 
predisposition to ASD (Skuse, 2000). The gender is a bimorphic genetic variation and there 
is a gender gap in sensitivity or vulnerability to environmental factors (Constantino & Todd, 
2003). The relationship between a bell-shaped quantitative distribution and the genetic 
factors underlying the complex phenotype still remains to be elucidated. 
5.1 Polygenic liability model 
The traditional concept of polygenic liability supposes a normal distribution of frequencies 
of susceptibility variant alleles (Gibson, 2009). The manner of the allele contribution is 
additive, and each allele contribution usually results in a positive or negative effect on the 
phenotype in the carrier individual and the quantitative population dimension results from 
such additive allele contributions. To explain the smooth normal distribution, an 
environmental variance of each allele contribution is addressed in this model. 
In a genetic model, oligogenicity with epistasis, the contributing genes are likely to be 
common ones in the population (Folstein & Rosen-Sheidley, 2001). There is no evidence that 
the genetic causative processes affecting the autistic extreme are different from those 
contributing the autistic dimension including individuals without autism (Ronald et al., 
2006a). If the presence of epistasis, pleiotropy, and gene-environment interactions are all 
supposed, the polymorphic genetic underpinning is referred to as QTLs (Plomin et al., 1994, 
2009; Plomin & Kosslyn, 2001). However, it is also the fact that the delay and difficulty in 
detecting the causal variant alleles at QTLs is common to all idiopathic quantitative traits 
including ASD, physical and physiological characteristics, and personalities (de Geus et al., 
2001; Fullerton, 2006; Palmert & Hirschhorn, 2003; Willis-Owen & Flint, 2006).  
If the genetic factors for a tail of the bell-shaped curve are different from those for the 
majority and have extremity-specific properties including serious involvement of coding 
gene segments (Mitchison, 2000), the variant alleles should be more detectable. Because the 
genetic contribution in ASD is the biggest in human complex traits and the environmental 
influence on ASD is quite minimal as described above, the difficulty in finding the universal 
genetic marker for ASD warrants the necessity of a paradigm shift. 
5.2 Additive and non-additive interactions between mono- and poly-morphic loci 
It has been emphasized that the three behavioral domains of ASD modestly correlate to each 
other and the set of genes for each domain may be partly different (Dworzynski et al., 2007; 
Happé et al., 2006; Ronald et al., 2005, 2006a, 2006b). The speculated modest genetic overlap 
among autistic domains may be indistinguishable from that among human complex 
phenotypes including ASD, bipolar disorder, and schizophrenia (Rzhetsky et al., 2007), 
suggesting that the autistic domains and these psychiatric conditions might share the same 
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genetic architecture at least in part (Craddock & Owen, 2010). In an argument about 
domain-specific genes for cognitive functions, it is expected that the domain-general genes 
are responsible for the brain infrastructure including receptors, neurotransmitters, dendritic 
spines, synapse vesicles, and axonal filaments (Marcus & Rabagliati, 2006). Although the 
universality of the domain-general genes for cognitive functions among other human 
complex phenotypes is controversial, genes for the brain infrastructure are also current 
topics in the field of ASD (Garber, 2007; Persico & Bourgeron, 2006). Both the heterogeneity 
of genetic markers for ASD and the modest correlation among autistic core domains can be 
explained by epistasis-mediated oscillation of the domain-general effect values and 
unsynchronized epistatic pleiotropy in the monomorphic loci theory, which never dismiss 
the comprehensive view of the known genetic contributions, including major gene effects 
and additive genetic networks (Ijichi et al., 2011). The assumption of the random outcomes 
mediated by the non-additive interactions between functional monomorphic loci and 
polymorphic backgrounds may transform the traditional complementary roles of some 
monomorphic loci (Gjuvsland et al., 2007) to active and leading roles for the phenotypic 
diversity (Ijichi et al., 2011). However, the controversy concerning the importance of non-
additive effects in phenotypic diversity still exists (Gale et al., 2009; Hill et al., 2008; 
Malmberg & Mauricio, 2005). 
5.3 Social environmental changes and decanalization 
The decanalization concept may have sizable significance in searching the cause of the 
maintained or increasing prevalence of ASD. Canalization is an evolutionary phenomenon 
characterized by robustness to genetic or environmental perturbation, and most individuals 
tend to cluster around the optimal phenotype in canalized populations (Gibson, 2009). If the 
phenotypic dimension consists of multiple endophenotypic vectors which have nonlinear 
relationships to each other and are partially determined by genetic factors, overt 
environmental perturbations for one of the endophenotypes can be the cue of 
decanalization, which changes the shape of the phenotypic demensional distribution 
(Gibson, 2009). Social environmental perturbations may also shift the entire distribution of 
ASD liability, or move the liability threshold. 
6. Conclusions 
The difficulty in detecting the universal biological marker for the predisposition to ASD 
presents significant challenges and conflicts to researchers in related fields. The reported 
gene variants in some sporadic cases with idiopathic ASD are nothing but one of the 
concomitants, until the molecular or biological trajectory underlying autistic development is 
clearly delineated or association studies reproduce the causal relationship. Before the 
speculation that idiopathic ASD represents many distinct conditions with numerous 
etiologies, the quantitative manner of the distribution of the behavioral domains and the fact 
that ASD is a mere tail of the behavioral dimensions should strictly be considered and 
emphasized. Even combinations of traditional theories including poor penetrance, de novo 
mutations, quantitative trait loci, and environmental contribution cannot fully account for 
the entire genetic underpinning. Importantly, the almost monolithic insight into the 
prevalence of ASD can only be obtained in an evolutionary framework on the assumption 
that the complex genetic networks are responsible not for the individual cases but for the 
human behavioral diversity itself. Gender differences, environmental factors, epigenetic 
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mechanisms including genetic imprinting, and major gene effects may all be mere accidental 
modifiers of the relationship between the diversity and the liability threshold. 
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